IBO ▲ +2.3% - Impact BioMedical Inc. $IBO - Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.) Impact BioMedical announced a 1-for-12.62 reverse stock split as it moves toward completing a merger with Zoar Ltd. Reverse stock splits are typically implemented to bring a stock's price into compliance with exchange listing requirements or to facilitate a corporate transaction, which in this case appears tied to the merger completion. The stock rose 2.3% following the announcement. 11-SEP-2026 04:05 PM ET